Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-001122
Date:2020-02-10
Issuer: CONSTELLATION PHARMACEUTICALS INC (CNST)
Original Submission Date:

Reporting Person:

VALENTINE KAREN
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200 CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-10 M 14,096 a $11.50 14,096 direct
COMMON STOCK 2020-02-10 S 14,096 d $33.51 0 direct
COMMON STOCK 2020-02-11 M 8,550 a $11.50 8,550 direct
COMMON STOCK 2020-02-11 S 8,550 d $35.03 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 11.5 2020-02-10 deemed execution date M 14,096 (d) 2028-07-18 common stock 14,096 $11.50 131,239 direct
STOCK OPTION (RIGHT TO BUY) 11.5 2020-02-11 deemed execution date M 8,550 (d) 2028-07-18 common stock 8,550 $11.50 122,689 direct
Footnotes
IDfootnote
f1 this transaction was executed in multiple trades at prices ranging from $32.37 to $35.00. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this transaction was executed in multiple trades at prices ranging from $35.00 to $35.10. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f3 this option was granted on july 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on july 16, 2019, with the remainder vesting in equal quarterly installments through july 16, 2022, subject to continued service.
WhaleWisdom Logo

Elevate your investments